These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2852244)

  • 21. Mapping out the intricate relationship of the HIV envelope protein and the membrane environment.
    Klug YA; Rotem E; Schwarzer R; Shai Y
    Biochim Biophys Acta Biomembr; 2017 Apr; 1859(4):550-560. PubMed ID: 27793589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.
    Ruegg CL; Monell CR; Strand M
    J Virol; 1989 Aug; 63(8):3257-60. PubMed ID: 2526228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
    Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
    Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte activation by HIV-1 envelope glycoprotein.
    Kornfeld H; Cruikshank WW; Pyle SW; Berman JS; Center DM
    Nature; 1988 Sep; 335(6189):445-8. PubMed ID: 2843775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160.
    Decroly E; Benjannet S; Savaria D; Seidah NG
    FEBS Lett; 1997 Mar; 405(1):68-72. PubMed ID: 9094426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in HIV-specific antibody responses and neutralization titers in patients under ART.
    Falkensammer B; Freissmuth D; Hübner L; Speth C; Dierich MP; Stoiber H
    Front Biosci; 2007 Jan; 12():2148-58. PubMed ID: 17127452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro.
    Gruber A; Lukasser-Vogl E; Borg-von Zepelin M; Dierich MP; Würzner R
    J Infect Dis; 1998 Apr; 177(4):1057-63. PubMed ID: 9534982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer predictions of antigenic domains in human immunodeficiency virus-1 envelope glycoprotein: comparison with reported experimental data.
    Becker Y
    Virus Genes; 1990 Apr; 3(4):323-41. PubMed ID: 1693457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity.
    Brand D; Lemiale F; Thibault G; Verrier B; Lebigot S; Roingeard P; Buzelay L; Brunet S; Barin F
    Virology; 2000 Jun; 271(2):350-62. PubMed ID: 10860888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the fusion peptide of primate immunodeficiency viruses.
    Bosch ML; Earl PL; Fargnoli K; Picciafuoco S; Giombini F; Wong-Staal F; Franchini G
    Science; 1989 May; 244(4905):694-7. PubMed ID: 2541505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods.
    Andreassen H; Bohr H; Bohr J; Brunak S; Bugge T; Cotterill RM; Jacobsen C; Kusk P; Lautrup B; Petersen SB
    J Acquir Immune Defic Syndr (1988); 1990; 3(6):615-22. PubMed ID: 2187072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibody against glycoproteins of human immunodeficiency virus.
    Sugano T; Masuho Y; Matsumoto Y; Lake D; Gschwind C; Petersen EA; Hersh EM
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1105-12. PubMed ID: 2845963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160.
    Sen J; Jacobs A; Jiang H; Rong L; Caffrey M
    Protein Sci; 2007 Jun; 16(6):1236-41. PubMed ID: 17525470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved antigenicity of the HIV env protein by cleavage site removal.
    Kieny MP; Lathe R; Rivière Y; Dott K; Schmitt D; Girard M; Montagnier L; Lecocq J
    Protein Eng; 1988 Sep; 2(3):219-25. PubMed ID: 3237686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
    Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.